Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01177969 · ClinicalTrials.gov registry record · Phase 1
Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
A Phase 1 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT01177969 is a Phase 1 study that has completed, run by University of South Florida. The registered enrollment target is 33 participants.
The verdict
NCT01177969, a Phase 1 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
Comorbid anxiety disorders affect as many as 80% of youth with autism spectrum disorders, causing substantial distress and impairment over and above the autism spectrum diagnosis alone. Cognitive behavioral therapy (CBT) is the gold standard treatment among typically developing youth with an anxiety disorder and when adapted, shows promise in children with ASD and comorbid anxiety. However, there is currently no psychotherapy protocol tailored to meet the unique needs of young adolescents with Autism spectrum disorders (ASD) and comorbid anxiety. Given this, the present study seeks to develop and test a new CBT therapy in adolescents with autism and comorbid anxiety.
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy
- BEHAVIORAL Wait-list
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01177969
The ClinicalTrials.gov registry entry for NCT01177969 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive-Behavioral Therapy is the first listed.
NCT01177969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01177969 about?
NCT01177969 is a clinical study titled "Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents". Comorbid anxiety disorders affect as many as 80% of youth with autism spectrum disorders, causing substantial distress and impairment over and above the autism spectrum diagnosis alone. Cognitive behavioral therapy (CBT) is the gold standard treatment among typically developing youth with an anxiety...
What is the current status of trial NCT01177969?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2009-11. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01177969?
The interventions under investigation include: Cognitive-Behavioral Therapy (BEHAVIORAL), Wait-list (BEHAVIORAL).
Who is sponsoring clinical trial NCT01177969?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.